PRecIsion MEdicine based on kidney TIssue Molecular interrogation in diabetic nEphropathy (PRIMETIME 1)
PRIMETIME 1 cohort is designed to study clinical characteristics, diagnostic accuracy and prognostic markers in a population with diabetes and kidney disease classified by biopsy. This retrospective Danish nationwide cohort includes over 2,500 individuals with diabetes who have undergone a kidney biopsy between the 1980s and 2022. The study combined multiple registries and medical databases to comprehensively describe the cohort with data on demographics, socioeconomic status, lifestyle, laboratory measurements, medication use and comorbidity at the time of diagnosis of diabetes and at the time of kidney biopsy within types of kidney disease.
Study design
Cohort - clinical, Registry
Number of participants at first data collection
2,586 (participants)
Age at first data collection
Varied (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
Adults diagnosed with diabetes in Denmark between 1996 and 2020 who had a kidney biopsy performed.
Sample features
Country
Year of first data collection
1968
Primary Institutions
Steno Diabetes Center Copenhagen
Zealand University Hospital, Roskilde
Profile paper DOI
Funders
Novo Nordisk Foundation
Region Zealand
Ongoing?
Yes
Data types collected
- Secondary data
- None
- None
- Census data
- Education data
- Employer data
- Healthcare data
- Mortality data
- Tax, income & benefit data
Engagement
Keywords
